The consensus price target for Emergent BioSolutions has shifted from US$15 to US$12, with the modeled fair value sitting at US$12 per share. Analysts link this move to reduced earnings expectations ...

Joe Papa, President and Chief Executive Officer, who will provide an update on the company's 2025 business performance and multiyear transformation plan highlights; and Rich Lindahl, EVP and Chief ...

Emergent Labs Inc., a vibe coding platform for building production-ready software, today announced the launch of Wingman, a ...

With nearly 6 million users and $100 million ARR in eight months, Emergent is turning vibe coding from an experiment into a ...

Emergent's Wingman lets users manage and automate tasks through chat on platforms like WhatsApp and Telegram.

Emergent's AI platform revolutionizes app creation by enabling non-technical users to build production-ready software.

The startup is launching Wingman, a personal AI agent that operates on messaging platforms like WhatsApp or iMessage.

Emergent is also building a new agent that will be able to run autonomously for hours without any instructions.

Once complete, Emergent’s $200-250 million round will be among the largest funding rounds so far this year. It will also be ...

About NARCAN ® Nasal Spray NARCAN ® Nasal Spray is a pure opioid antagonist indicated for emergency use to reverse known or suspected opioid overdose, as manifested by respiratory and/or severe ...

Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid overdoses, is expanding its arsenal of medical countermeasures by scooping up global ...

Under a pre-emergency use authorization, Emergent BioSolutons has provided the Department of Health and Human Services with its AV7909 anthrax vaccine for emergency preparedness since 2019. Four years ...